usually resolves within 12 weeks per dose Diarrhoea particularly during the first 46 weeks Constipation often develops in weeks 412 as gastric emptying slows Abdominal discomfort and bloating Reduced appetite this is the therapeutic effect, but can feel intense at first Fatigue often related to reduced caloric intake rather than the drug itself Discontinuation rates in ATTAIN-1 were higher with orforglipron than placebo typically due to persistent GI symptoms during dose escalation
Neither form is universally superior, the right choice depends on the individual patients preferences, clinical goals, and circumstances
Practical management strategies can significantly improve tolerability
Oh and I forgot to mention a really important factor as well
Manish Sahni, MD Table of Contents: What are the expected benefits of using Semaglutide GLP-1 for weight management
Right, Ozempic, its not a manufacturing issue, its more a demand issue thats going on